| Year |
Citation |
Score |
| 2023 |
Nes MS, Haugen M, Haugland HK, Gilhus NE, Vedeler CA. Case report: Seropositive myasthenia gravis complicated by limbic encephalitis positive for antibodies to AMPAR and Lgi1. Frontiers in Neurology. 14: 1237140. PMID 37900608 DOI: 10.3389/fneur.2023.1237140 |
0.496 |
|
| 2020 |
Kråkenes T, Herdlevaer I, Raspotnig M, Haugen M, Schubert M, Vedeler C. Reply to "CDR2 and CDR2L Antigens in Paraneoplastic Cerebellar Degeneration". Annals of Neurology. PMID 32445220 DOI: 10.1002/Ana.25794 |
0.319 |
|
| 2016 |
Sundal C, Vedeler C, Miletic H, Andersen O. Morvan syndrome with Caspr2 antibodies. Clinical and autopsy report. Journal of the Neurological Sciences. PMID 27802867 DOI: 10.1016/J.Jns.2016.10.046 |
0.333 |
|
| 2016 |
Waters P, Reindl M, Saiz A, Schanda K, Tuller F, Kral V, Nytrova P, Sobek O, Nielsen HH, Barington T, Lillevang ST, Illes Z, Rentzsch K, Berthele A, Berki T, ... ... Vedeler C, et al. Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27113605 DOI: 10.1136/Jnnp-2015-312601 |
0.383 |
|
| 2015 |
Waje-Andreassen U, Naess H, Thomassen L, Maroy TH, Mazengia KY, Eide GE, Vedeler CA. Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke. Translational Stroke Research. 6: 276-83. PMID 25948070 DOI: 10.1007/S12975-015-0403-0 |
0.529 |
|
| 2015 |
Raspotnig M, Vedeler C, Storstein A. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies. Journal of the Neurological Sciences. 348: 41-5. PMID 25467140 DOI: 10.1016/J.Jns.2014.10.040 |
0.334 |
|
| 2014 |
Schubert M, Panja D, Haugen M, Bramham CR, Vedeler CA. Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. Acta Neuropathologica. 128: 835-52. PMID 25341622 DOI: 10.1007/S00401-014-1351-6 |
0.728 |
|
| 2014 |
Schubert M, Eichler T, Haugen M, Vedeler C. Paraneoplastic cerebellar degeneration: Auto-antibodies cause damage to Purkinje cells by changing the calcium homeostasis Journal of Neuroimmunology. 275: 38-39. DOI: 10.1016/J.Jneuroim.2014.08.103 |
0.321 |
|
| 2013 |
Fromm A, Thomassen L, Naess H, Meijer R, Eide GE, Kråkenes J, Vedeler CA, Gerdts E, Larsen TH, Kuiper KK, Laxdal E, Russell D, Tatlisumak T, Waje-Andreassen U. The Norwegian Stroke in the Young Study (NOR-SYS): rationale and design. Bmc Neurology. 13: 89. PMID 23865483 DOI: 10.1186/1471-2377-13-89 |
0.514 |
|
| 2013 |
Totland C, Ying M, Haugen M, Mazengia K, Storstein A, Aarseth J, Martinez A, Vedeler C. Avidity of onconeural antibodies is of clinical relevance. Cancer Immunology, Immunotherapy : Cii. 62: 1393-6. PMID 23733227 DOI: 10.1007/S00262-013-1442-6 |
0.39 |
|
| 2013 |
Waje-Andreassen U, Thomassen L, Jusufovic M, Power KN, Eide GE, Vedeler CA, Naess H. Ischaemic stroke at a young age is a serious event--final results of a population-based long-term follow-up in Western Norway. European Journal of Neurology. 20: 818-823. PMID 23293975 DOI: 10.1111/Ene.12073 |
0.516 |
|
| 2012 |
Giometto B, Vitaliani R, Lindeck-Pozza E, Grisold W, Vedeler C. Treatment for paraneoplastic neuropathies. The Cochrane Database of Systematic Reviews. 12: CD007625. PMID 23235647 DOI: 10.1002/14651858.Cd007625.Pub2 |
0.305 |
|
| 2012 |
Gavasso S, Gjertsen B, Anderssen E, Myhr K, Vedeler C. Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis: Multiple Sclerosis Journal. 18: 1116-1124. PMID 22287540 DOI: 10.1177/1352458511434066 |
0.308 |
|
| 2011 |
Sørensen PS, Jensen PE, Haghikia A, Lundkvist M, Vedeler C, Sellebjerg F, Koch-Henriksen N, Fogdell-Hahn A, Myhr KM, Hillert J, Gold R. Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1074-8. PMID 21511692 DOI: 10.1177/1352458511404271 |
0.385 |
|
| 2011 |
Storstein A, Monstad SE, Haugen M, Mazengia K, Veltman D, Lohndal E, Aarseth J, Vedeler C. Onconeural antibodies: improved detection and clinical correlations. Journal of Neuroimmunology. 232: 166-70. PMID 21093932 DOI: 10.1016/J.Jneuroim.2010.10.009 |
0.418 |
|
| 2010 |
Titulaer MJ, Soffietti R, Dalmau J, Gilhus NE, Giometto B, Graus F, Grisold W, Honnorat J, Sillevis Smitt PA, Tanasescu R, Vedeler CA, Voltz R, Verschuuren JJ. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. European Journal of Neurology. 18: 19-e3. PMID 20880069 DOI: 10.1111/J.1468-1331.2010.03220.X |
0.382 |
|
| 2010 |
Petzold A, Altintas A, Andreoni L, Bartos A, Berthele A, Blankenstein MA, Buee L, Castellazzi M, Cepok S, Comabella M, Constantinescu CS, Deisenhammer F, Deniz G, Erten G, Espiño M, ... ... Vedeler C, et al. Neurofilament ELISA validation. Journal of Immunological Methods. 352: 23-31. PMID 19857497 DOI: 10.1016/J.Jim.2009.09.014 |
0.474 |
|
| 2010 |
Totland C, Bredholt G, Haugen M, Haukanes BI, Vedeler CA. Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo). Cancer Immunology, Immunotherapy : Cii. 59: 231-7. PMID 19680650 DOI: 10.1007/s00262-009-0742-3 |
0.302 |
|
| 2009 |
Vedeler CA, Nyland H, Matre R. In situ characterization of the foam cells in early human atherosclerotic lesions Acta Pathologica Microbiologica Scandinavica Series C: Immunology. 92: 133-137. PMID 6375254 DOI: 10.1111/J.1699-0463.1984.Tb00064.X |
0.561 |
|
| 2009 |
Vedeler CA, Nyland H. Plasma exchange in Guillain-Barré syndrome: effect on anti-peripheral nerve myelin antibodies. Acta Neurologica Scandinavica. 82: 147-149. PMID 2256446 DOI: 10.1111/J.1600-0404.1990.Tb01606.X |
0.302 |
|
| 2009 |
Vedeler CA, Gilhus NE, Matre R. Expression of complement C3b/C4b receptors (CR1) on erythrocytes from patients with myasthenia gravis Acta Neurologica Scandinavica. 82: 259-262. PMID 2148662 DOI: 10.1111/J.1600-0404.1990.Tb01616.X |
0.629 |
|
| 2008 |
Waje-Andreassen U, Naess H, Thomassen L, Eide GE, Meijer R, Vedeler CA. Ultrasound, atherosclerosis and stroke at a young age: a cross‐sectional long‐term follow‐up in western Norway European Journal of Neurology. 15: 512-519. PMID 18355304 DOI: 10.1111/J.1468-1331.2008.02118.X |
0.53 |
|
| 2008 |
Monstad SE, Drivsholm L, Skeie GO, Aarseth JH, Vedeler CA. CRMP5 antibodies in patients with small-cell lung cancer or thymoma. Cancer Immunology, Immunotherapy : Cii. 57: 227-32. PMID 17657489 DOI: 10.1007/s00262-007-0369-1 |
0.313 |
|
| 2007 |
Waje-Andreassen U, Naess H, Thomassen L, Eide GE, Vedeler CA. Long-term mortality among young ischemic stroke patients in western Norway. Acta Neurologica Scandinavica. 116: 150-156. PMID 17714327 DOI: 10.1111/J.1600-0404.2007.00822.X |
0.523 |
|
| 2007 |
Waje-Andreassen U, Naess H, Thomassen L, Eide GE, Vedeler CA. Arterial events after ischemic stroke at a young age: a cross-sectional long-term follow-up of patients and controls in western Norway. Cerebrovascular Diseases (Basel, Switzerland). 24: 277-82. PMID 17646692 DOI: 10.1159/000105680 |
0.519 |
|
| 2007 |
Totland C, Aarseth J, Vedeler C. Hu and Yo antibodies have heterogeneous avidity. Journal of Neuroimmunology. 185: 162-7. PMID 17336396 DOI: 10.1016/J.Jneuroim.2007.01.016 |
0.39 |
|
| 2007 |
Mygland Å, Trydal T, Vinje BU, Vedeler C. Isoelectric focusing is superior to immunofixation electrophoresis in diagnosing CNS inflammation. Acta Neurologica Scandinavica. 115: 122-125. PMID 17212616 DOI: 10.1111/J.1600-0404.2006.00763.X |
0.32 |
|
| 2006 |
Gavasso S, Myhr K-, Vedeler C. Multiplexed phosphoprotein analysis in immune cells. Acta Neurologica Scandinavica. 113: 58-60. PMID 16637932 DOI: 10.1111/J.1600-0404.2006.00618.X |
0.301 |
|
| 2006 |
Gilhus NE, Tysnes O, Vedeler CA. Introduction Acta Neurologica Scandinavica. 113: v-vi. DOI: 10.1111/j.1600-0404.2006.00604.x |
0.354 |
|
| 2005 |
Storstein A, Knudsen A, Vedeler CA. Proteasome antibodies in paraneoplastic cerebellar degeneration. Journal of Neuroimmunology. 165: 172-8. PMID 15964637 DOI: 10.1016/j.jneuroim.2005.04.024 |
0.318 |
|
| 2005 |
Waje-Andreassen U, Kråkenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J, Vedeler CA. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurologica Scandinavica. 111: 360-5. PMID 15876336 DOI: 10.1111/j.1600-0404.2005.00416.x |
0.508 |
|
| 2005 |
Waje-Andreassen U, Krakenes J, Ulvestad E, Thomassen L, Myhr K, Aarseth J, Vedeler CA. Response to: 'Interleukin-6 and acute ischaemic stroke' Acta Neurologica Scandinavica. 112: 275-275. DOI: 10.1111/j.1600-0404.2005.00481.x |
0.494 |
|
| 2004 |
Pedersen ED, Waje-Andreassen U, Vedeler CA, Aamodt G, Mollnes TE. Systemic complement activation following human acute ischaemic stroke. Clinical and Experimental Immunology. 137: 117-22. PMID 15196251 DOI: 10.1111/J.1365-2249.2004.02489.X |
0.533 |
|
| 2004 |
Monstad SE, Drivsholm L, Storstein A, Aarseth JH, Haugen M, Lang B, Vincent A, Vedeler CA. Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer Journal of Clinical Oncology. 22: 795-800. PMID 14990634 DOI: 10.1200/JCO.2004.01.028 |
0.301 |
|
| 2004 |
Ulvestad E, Aarseth JH, Vedeler C, Nyland H, Myhr K-. The Effects of Interferon-α2a on Concentrations of Immunoglobulins, Complement and Lymphocytes in Patients with Multiple Sclerosis Scandinavian Journal of Immunology. 59: 103-108. PMID 14723628 DOI: 10.1111/J.0300-9475.2004.01360.X |
0.308 |
|
| 2003 |
Farbu E, Rekand T, Tysnes O-, Aarli JA, Gilhus NE, Vedeler CA. GM1 antibodies in post-polio syndrome and previous paralytic polio. Journal of Neuroimmunology. 139: 141-144. PMID 12799031 DOI: 10.1016/S0165-5728(03)00123-1 |
0.519 |
|
| 2003 |
Sadallah S, Hess C, Trendelenburg M, Vedeler C, Lopez-Trascasa M, Schifferli JA. Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients. Clinical and Experimental Immunology. 131: 174-181. PMID 12519402 DOI: 10.1046/J.1365-2249.2003.02045.X |
0.344 |
|
| 2000 |
Willison H, Ang W, Gilhus NE, Graus F, Liblau R, Vedeler C, Vincent A. EFNS Task Force Report: a questionnaire‐based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres European Journal of Neurology. 7: 625-628. PMID 11136347 DOI: 10.1046/J.1468-1331.2000.00158.X |
0.506 |
|
| 2000 |
Romi F, Skeie GO, Vedeler C, Aarli JA, Zorzato F, Gilhus NE. Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations. Journal of Neuroimmunology. 111: 169-76. PMID 11063835 DOI: 10.1016/S0165-5728(00)00394-5 |
0.579 |
|
| 1999 |
Myhr K, Raknes G, Nyland H, Vedeler C. Immunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in MS Neurology. 52: 1771-1771. PMID 10371522 DOI: 10.1212/Wnl.52.9.1771 |
0.315 |
|
| 1998 |
Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Grønning M, Kalvenes MB, Nyland H. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. Journal of Neurology, Neurosurgery, and Psychiatry. 64: 539-42. PMID 9576551 DOI: 10.1136/Jnnp.64.4.539 |
0.315 |
|
| 1998 |
Raknes G, Skeie GO, Gilhus NE, Aadland S, Vedeler C. FcγRIIA and FcγRIIIB polymorphisms in myasthenia gravis Journal of Neuroimmunology. 81: 173-176. PMID 9521619 DOI: 10.1016/S0165-5728(97)00174-4 |
0.52 |
|
| 1996 |
Vedeler CA, Matre R, Sadallah S, Schifferli J. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis. Journal of Neuroimmunology. 67: 17-20. PMID 8707926 DOI: 10.1016/0165-5728(96)00035-5 |
0.525 |
|
| 1995 |
Conti G, Baron PL, Scarpini E, Vedeler C, Rostami A, Pleasure DE, Scarlato G. Low-affinity nerve growth factor receptor expression in sciatic nerve during P2-peptide induced experimental allergic neuritis Neuroscience Letters. 199: 135-138. PMID 8584242 DOI: 10.1016/0304-3940(95)12043-4 |
0.304 |
|
| 1995 |
Bjørge L, Jensen TS, Ulvestad E, Vedeler CA, Matre R. The Influence of Tumour Necrosis Factor‐γ, Interleukin‐1β and Interferon‐γ on the Expression and Function of the Complement Regulatory Protein CD59 on the Human Colonic Adenocarcinoma Cell Line HT29 Scandinavian Journal of Immunology. 41: 350-356. PMID 7534941 DOI: 10.1111/J.1365-3083.1995.Tb03578.X |
0.485 |
|
| 1994 |
Kristoffersen EK, Matre R, Ulvestad E, Vedeler CA. A dot-immunobinding assay for the demonstration of soluble Fcγ receptors Journal of Immunological Methods. 167: 15-19. PMID 8308274 DOI: 10.1016/0022-1759(94)90070-1 |
0.541 |
|
| 1994 |
Vedeler C, Ulvestad E, Grundt I, Conti G, Nyland H, Matre R, Pleasure DE. Fc receptor for IgG (FcR) on rat microglia Journal of Neuroimmunology. 49: 19-24. PMID 8294556 DOI: 10.1016/0165-5728(94)90176-7 |
0.545 |
|
| 1994 |
Ulvestad E, Williams K, Vedeler C, Antel J, Nyland H, Mørk S, Matre R. Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. Journal of the Neurological Sciences. 121: 125-131. PMID 8158203 DOI: 10.1016/0022-510X(94)90340-9 |
0.593 |
|
| 1994 |
Vedeler C, Ulvestad E, Nyland H, Matre R, Aarli JA. Receptors for gammaglobulin in the central and peripheral nervous system Journal of Neurology, Neurosurgery, and Psychiatry. 57: 9-10. PMID 7964862 DOI: 10.1136/Jnnp.57.Suppl.9 |
0.556 |
|
| 1994 |
Bjørge L, Vedeler CA, Ulvestad E, Matre R. Expression and function of CD59 on colonic adenocarcinoma cells. European Journal of Immunology. 24: 1597-603. PMID 7517877 DOI: 10.1002/EJI.1830240722 |
0.507 |
|
| 1993 |
Bjørge L, Jensen TS, Vedeler CA, Ulvestad E, Kristoffersen EK, Matre R. Soluble CD59 in pregnancy and infancy. Immunology Letters. 36: 233-233. PMID 7688713 DOI: 10.1016/0165-2478(93)90058-A |
0.445 |
|
| 1993 |
Iversen BM, Vedeler CA, Matre R, Svarstad E. CR1 activity on erythrocytes and renal glomeruli in patients with renal disorders Nephrology Dialysis Transplantation. 8: 1211-1214. DOI: 10.1093/Ndt/8.11.1211 |
0.498 |
|
| 1991 |
Fredman P, Vedeler CA, Nyland H, Aarli JA, Svennerholm L. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. Journal of Neurology. 238: 75-79. PMID 1856740 DOI: 10.1007/Bf00315684 |
0.302 |
|
| 1991 |
Vedeler CA, Matre R, Kristoffersen EK, Ulvestad E. IgG Fc receptor heterogeneity in human peripheral nerves. Acta Neurologica Scandinavica. 84: 177-180. PMID 1835241 DOI: 10.1111/J.1600-0404.1991.Tb04933.X |
0.573 |
|
| 1990 |
Vedeler CA, Matre R. Peripheral nerve CR1 express in situ cofactor activity for degradation of C3b. Journal of Neuroimmunology. 26: 51-56. PMID 2403574 DOI: 10.1016/0165-5728(90)90119-8 |
0.573 |
|
| 1990 |
Vedeler CA, Gilhus NE, Matre R. Erythrocyte C3b/C4b receptors (CR1) in patients with myasthenia gravis. Autoimmunity. 6: 235-236. PMID 2151792 DOI: 10.3109/08916939009041043 |
0.627 |
|
| 1990 |
Kristoffersen EK, Ulvestad E, Vedeler CA, Matre R. Fcγ Receptor Heterogeneity in the Human Placenta Scandinavian Journal of Immunology. 32: 561-564. PMID 2148639 DOI: 10.1111/J.1365-3083.1990.Tb03197.X |
0.488 |
|
| 1990 |
Vedeler CA, Matre R, Iversen BM. Glomerular CR1 express in situ cofactor activity for degradation of C3b. International Archives of Allergy and Immunology. 92: 60-63. PMID 2147176 DOI: 10.1159/000235225 |
0.564 |
|
| 1990 |
Vedeler CA, Matre R. Peripheral nerve CR1 limit complement-mediated haemolysis Journal of Neuroimmunology. 30: 95-98. PMID 2146286 DOI: 10.1016/0165-5728(90)90056-S |
0.548 |
|
| 1990 |
Vedeler CA, Scarpini E, Beretta S, Doronzo R, Matre R. The ontogenesis of Fc gamma receptors and complement receptors CR1 in human peripheral nerve. Acta Neuropathologica. 80: 35-40. PMID 2141750 DOI: 10.1007/BF00294219 |
0.552 |
|
| 1989 |
Matre R, Kristoffersen EK, Ulvestad E, Vedeler CA. Purification of a functional 40 kD human placental Fcγ‐receptor using a monoclonal antibody Apmis. 97: 733-737. PMID 2527523 DOI: 10.1111/J.1699-0463.1989.Tb00470.X |
0.56 |
|
| 1989 |
Vedeler CA, Matre R, Fischer E. Isolation and characterization of complement receptors CR1 from human peripheral nerves. Journal of Neuroimmunology. 23: 215-221. PMID 2526822 DOI: 10.1016/0165-5728(89)90053-2 |
0.547 |
|
| 1989 |
Vedeler CA, Matre R, Kristoffersen EK. Solubilization of human peripheral nerve Fcγ receptors and purification of a functional 40 kDa receptor Immunology Letters. 22: 281-285. PMID 2516836 DOI: 10.1016/0165-2478(89)90166-1 |
0.565 |
|
| 1989 |
Vedeler CA, Nilsen R, Matre R. Localization of Fcγ receptors and complement receptors CR1 on human peripheral nerve fibres by immunoelectron microscopy Journal of Neuroimmunology. 23: 29-33. PMID 2470779 DOI: 10.1016/0165-5728(89)90069-6 |
0.552 |
|
| 1988 |
Osterman PO, Vedeler CA, Ryberg B, Fagius J, Nyland H. Serum antibodies to peripheral nerve tissue in acute Guillain-Barré syndrome in relation to outcome of plasma exchange. Journal of Neurology. 235: 285-289. PMID 3385444 DOI: 10.1007/Bf00314175 |
0.317 |
|
| 1988 |
Vedeler CA, Matre R. Complement receptors CR1 on human peripheral nerve fibres Journal of Neuroimmunology. 17: 315-322. PMID 2963017 DOI: 10.1016/0165-5728(88)90122-1 |
0.565 |
|
| 1988 |
Vedeler CA, Matre R, Nyland H. Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy. Acta Neurologica Scandinavica. 78: 401-407. PMID 2464267 DOI: 10.1111/J.1600-0404.1988.Tb03676.X |
0.596 |
|
| 1987 |
Vedeler CA. Demonstration of Fc gamma receptors on human peripheral nerve fibres. Journal of Neuroimmunology. 15: 207-16. PMID 2953759 DOI: 10.1016/0165-5728(87)90094-4 |
0.31 |
|
| 1987 |
Matre R, Vedeler CA, Halvorsen OJ. Expression of glomerular C3b receptor activity in normal human kidneys. Immunology Letters. 14: 321-323. PMID 2953678 DOI: 10.1016/0165-2478(87)90012-5 |
0.521 |
|
| 1987 |
Matre R, Vedeler CA. Demonstration of human erythrocyte C3b receptors (CR1) by haemadsorption and indirect haemagglutination techniques. Journal of Immunological Methods. 96: 139-144. PMID 2949019 DOI: 10.1016/0022-1759(87)90378-4 |
0.518 |
|
| 1986 |
Vedeler CA, Matre R, Nyland H. Immunoglobulins in serum and cerebrospinal fluid from patients with acute Guillain-Barré syndrome Acta Neurologica Scandinavica. 73: 388-393. PMID 3727914 DOI: 10.1111/J.1600-0404.1986.Tb03294.X |
0.555 |
|
| 1986 |
Vedeler CA, Matre R, Nyland H, Møller P. Immunoglobulins, Complement Components and Lymphocyte Subpopulations in Bell’s Palsy European Neurology. 25: 177-182. PMID 3486122 DOI: 10.1159/000116006 |
0.539 |
|
| 1984 |
Nyland H, Vedeler CA, Matre R, Halvorsen K, Fagius J, Osterman PO, Janzen RWC, Skre H. Plasma exchange in patients with Guillain-Barré syndrome: clinical improvement in patients with serum IgG antibodies to peripheral nerve tissue. International Journal of Artificial Organs. 7: 133-136. DOI: 10.1177/039139888400700306 |
0.586 |
|
| 1982 |
Vedeler CA, Nyland H, Matre R. Antibodies to peripheral nerve tissue in sera from patients with acute Guillain-Barré syndrome demonstrated by a mixed haemagglutination technique Journal of Neuroimmunology. 2: 209-214. PMID 7085862 DOI: 10.1016/0165-5728(82)90055-8 |
0.587 |
|
| 1982 |
Vedeler CA, Nyland H, Fagius J, Osterman PO, Matre R, Aarli JA, Janzen RWC, Jacobsen H, Skre H. The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients with Guillain-Barré syndrome Journal of Neurology. 228: 59-64. PMID 6184459 DOI: 10.1007/Bf00313410 |
0.579 |
|
| Show low-probability matches. |